Osterix-Cre marks distinct subsets of CD45- and CD45+ stromal populations in extra-skeletal tumors with pro-tumorigenic characteristics is a research paper published in eLife (2020). On theSindex it has a DataRank of 0.828. It has been cited 24 times, with 17 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0.345
From 14 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 17 citers.
National Institutes of Health
Grant: R01 CA235096
National Institutes of Health
Grant: R01 AR066551
Shriners Hospital
Grant: P19-07408CR
JIT Award by Washinghton University Institute for Clinical and Translational Sciences
Grant: TR000448
NCATS NIH HHS
Grant: UL1 TR000448
NIAMS NIH HHS
Grant: P30 AR057235
NCATS NIH HHS
Grant: UL1 TR002345
NIAMS NIH HHS
Grant: P30 AR074992
NCI NIH HHS
Grant: P30 CA091842
National Institutes of Health
Grant: 5R01AR066551-03
Novel Regulators of Inflammatory Arthritis and Bone Erosion
National Institutes of Health
Grant: 5R01CA235096-05
Role of Bone in Primary and Metastatic Cancer
National Institutes of Health
Grant: 5P30AR057235-07
In Situ Molecular Analysis
National Institutes of Health
Grant: 1P30AR074992-01
Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)
National Institutes of Health
Grant: 1UL1TR002345-01
Washington University Institute of Clinical and Translational Sciences
National Institutes of Health
Grant: 4UL1TR000448-10
Washington University Institute of Clinical and Translational Sciences
National Institutes of Health
Grant: 5P30CA091842-05
Core--Pharmacology Facility
Siteman Cancer Center
FWCI
1.18
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals